PEGASPARGASE Side Effects

6222074-8 | Apolipoprotein Abnormal, Enzyme Abnormality, Hypertriglyceridaemia, Hypoglycaemia
on Jun 08, 2009 Male patient from UNITED STATES , weighting 117.5 lb, was diagnosed with acute leukaemia and was treated with Pegaspargase (View Usage). Patient experienced the following unwanted or unexpected effects: apolipoprotein abnormal, enzyme abnormality, hypertriglyceridaemia, hypoglycaemia. Pegaspargase dosage: 3,750-4,000 Units X3 Im. Patient was hospitalized.

6062751-5 | Angioedema, Anxiety, Hypersensitivity, Lip Swelling, Respiratory Distress, Urticaria, Vomiting
Patient was taking Pegaspargase (View Usage). Patient had the following side effects: angioedema, anxiety (What is anxiety?), hypersensitivity, lip swelling, respiratory distress, urticaria, vomiting on Feb 02, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 77.16 lb, was diagnosed with t-cell type acute leukaemia and. Pegaspargase dosage: 3,000 Unites X3 Im. Patient was hospitalized.

5379709-1 | Agitation, Coma, Confusional State, Csf Shunt Operation, Extensor Plantar Response, Hydrocephalus, Intracranial Pressure Increased, Lumbar Puncture, Meningitis
Adverse event was reported on Jun 29, 2007 by a Male patient taking Pegaspargase (View Usage) (Dosage: 4000 Iu, Once/single) was diagnosed with acute lymphocytic leukaemia and. Location: GERMANY , 55 years of age, weighting 200.6 lb, After Pegaspargase was administered, patient had the following side effects: agitation, coma, confusional state, csf shunt operation, extensor plantar response, hydrocephalus (What is hydrocephalus?), intracranial pressure increased, lumbar puncture, meningitis (What is meningitis?). During the same period patient was treated with GLEEVEC (600 Mg/day) (View Gleevec Review and Gleevec Label ). Patient was hospitalized.

5163773-9 | Ammonia Increased, Cognitive Disorder, Dialysis, Hepatic Failure
on Nov 27, 2006 Female patient from UNITED STATES , 13 years of age, weighting 233.7 lb, was diagnosed with acute lymphocytic leukaemia recurrent and was treated with Pegaspargase (View Usage). Patient experienced the following unwanted or unexpected effects: ammonia increased, cognitive disorder, dialysis (What is dialysis?), hepatic failure. Pegaspargase dosage: 2500 Units/m2/dose 5 Doses Im. Patient was hospitalized.


4990188-6 | Diarrhoea, Headache, Intracranial Venous Sinus Thrombosis, Malaise, Pyrexia, Superior Sagittal Sinus Thrombosis, Transverse Sinus Thrombosis, Vomiting
on May 01, 2006 Male patient from UNITED STATES , child 11 years of age, weighting 94.80 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Pegaspargase (View Usage). Patient had the following side effects: diarrhoea, headache (What is headache?), intracranial venous sinus thrombosis, malaise, pyrexia, superior sagittal sinus thrombosis, transverse sinus thrombosis, vomiting. Pegaspargase dosage: . Patient was hospitalized.

4755445-7 | Cough, Urticaria, Vomiting
Patient was taking Pegaspargase (View Usage). After Pegaspargase was administered, patient had the following side effects: cough, urticaria, vomiting on Aug 26, 2005 from UNITED STATES Additional patient health information: Male patient , child 3 years of age, was diagnosed with acute lymphocytic leukaemia, b-cell type acute leukaemia and. Pegaspargase dosage: Intramuscular ; 1625.0. During the same period patient was treated with ONCASPAR (View Oncaspar Review and Oncaspar Label ), ENZON (View Enzon Review and Enzon Label ), ANTINEOPLASTICS (View Antineoplastics Review and Antineoplastics Label ). Patient was hospitalized.

4665591-4 | Hyperglycaemia, Pancreatitis
Adverse event was reported on May 18, 2005 by a Male patient taking Pegaspargase (View Usage) (Dosage: 2400 Units Once Im) was diagnosed with acute lymphocytic leukaemia and. Location: , 19 years of age, weighting 136.7 lb, Patient experienced the following unwanted or unexpected effects: hyperglycaemia, pancreatitis. During the same period patient was treated with METHOTREXATE (15 Mg Once Intrathecal) (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.